ପାଟି କ୍ୟାନ୍ସର
This study involved people with oral cancer and looked at how well a new saliva-based testing device could tell if their treatment was working, if the cancer might come back, and how well they were recovering compared to the usual methods like biopsies and medical scans.
ହସ୍ପିଟାଲ ସହିତ ଯୋଗାଯୋଗ କରନ୍ତୁ
ରେଜିଷ୍ଟ୍ରି ଏହି ହସ୍ପିଟାଲକୁ ଟ୍ରାଏଲର ମୁଖ୍ୟ ଯୋଗାଯୋଗ ଭାବରେ ନାମିତ କରିଛି। ସେମାନଙ୍କୁ ପଚାରନ୍ତୁ କେଉଁ ହସ୍ପିଟାଲ ରୋଗୀ ନେଉଛନ୍ତି।
ରେଜିଷ୍ଟ୍ରି ସାରାଂଶ (ଟେକ୍ନିକାଲ୍)
A Prospective, Multi-Centre, Performance Evaluation Study to Determine the Accuracy of Saliscope, A Saliva Based Companion Diagnostic Assay in Predicting Chemotherapeutic Response, Relapse Propensity and Immunotherapeutic Efficacy in Oral Squamous Cell Carcinoma Patients, in Comparison to Conventional Histopathology Evaluation and RECIST Guidelines - NIL
Sponsor: Genoscope Private Limited
CTRI/2026/06/112560 on CTRI, India's trial registry
ଉତ୍ସ: Clinical Trials Registry – India (CTRI), WHO ICTRP ମାଧ୍ୟମରେ, ତଥ୍ୟ 12 Oct 2026
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 5 Oct 2026 · ଆମ ଦ୍ୱାରା 5 Nov 2026 ରେ ପଢ଼ାଯାଇଛି